Rock Point Advisors, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1301540
BURLINGTON, VT
Position in REGN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$236,945
-$56,658 QoQ
Shares Held
380
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,002
of 1,322 holders
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rock Point Advisors, LLC holds $236,945 across 1 Biotechnology name. REGN ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
380 | $236,945 |
All Filings in REGN
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $236,945 | 380 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $293,603 | 380 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $293,310 | 380 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $213,662 | 380 | Shares | Sole | 2025-11-12 | |
| 2025-03-31 | $241,007 | 380 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $270,685 | 380 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $399,471 | 380 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $399,391 | 380 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $365,746 | 380 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $333,750 | 380 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $329,184 | 400 | Shares | Sole | 2023-11-09 | |
| No filing history on record for this holder in this stock. | ||||||